TrialDiabetes2011

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.

Hyun-Seuk Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.